TIDHI Innovation Inc.

Toronto, Ontario M6A3B4

2 studies enrolling now · 2 studies all time

What they study most

Moderately to Severely Active Ulcerative Colitis, Ulcerative Colitis

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• Mirikizumab Real World Protocol — Recruiting now